Перевести на Переведено сервисом «Яндекс.Перевод»

Alnylam Pharmaceuticals, Inc

Country
USA
Краткое название
Alnylam Pharmaceuticals, Inc
Headquarters
300 Third Street 3rd Floor
Members of the board

John Maraganore, Ph. D., Chief Executive Officer Barry Greene, President and Chief Operating Officer Laurence Reid, Ph. D., Senior Vice President, Chief Business Officer Akshay Vaishnaw, M.D., Ph. D., Executive Vice President and Chief Medical Officer Oved Amitay, Vice President, Head of Commercial Steve Bossone, Ph. D., Vice President, Intellectual Property Cynthia Clayton, Vice President, Investor Relations and Corporate Communications Mary Beth DeLena, Vice President, Associate General Counsel Jared Gollob, M.D., Vice President, Clinical Research SСШАnna High, Vice President, Business Planning and Program Management David Konys, Vice President, Manufacturing Operations Muthiah (Mano) Manoharan, Ph. D., Senior Vice President, Drug Discovery Michael Mason, Vice President Finance and Treasurer Rachel Meyers, Ph. D., Vice President, Research and RLD Lubomir (Lubo) Nechev, Ph. D., Vice President, Process Sciences Saraswathy (Sara) Nochur, Ph. D., Senior Vice President, Regulatory Affairs & Qaulity Assurance Eric Raichle, Vice President, Sara Nochur, Ph. D., Senior Vice President, Regulatory Affairs & Qaulity Assurance Eric Raichle, Vice President, Human Resources Garvin Warner, Ph. D., Vice President, Pre-Clinical Development

Categories medicine
Infectious diseases
Stage of the project
Production
Disease
HIV, Viral hepatitis, Tuberculosis, Influenza
Ticker
ALNY
Current owners
John Clarke Dennis Ausiello, M.D. Victor Dzau, M.D. Marsha H. Fanucci John Maraganore, Ph.D. Steven M. Paul, M.D Paul Schimmel, Ph.D. Phillip Sharp, Ph.D. Kevin Starr
Assets
10.4200
Technology
Pharmaceuticals